                         SEQUENCE LISTING

<110>  Oxford University Innovation Limited
 
<120>  TREATMENT OF DISORDERS ASSOCIATED WITH LOW BH4 BIOAVAILABILITY

<130>  P304046WO

<140>  PCT/GB2021/053382
<141>  2021-12-21

<150>  GB2020285.9
<151>  2020-12-21

<150>  GB2108231.8
<151>  2021-06-09

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Gch1 fl/fl  Fw primer

<400>  1
gtccttggtc tcagtaaact tgccagg                                           27


<210>  2
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Gch1 fl/fl Rv primer

<400>  2
gcccagccaa ggatagatgc ag                                                22


<210>  3
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tie2cre Fw primer

<400>  3
gcataaccag tgaaacagca ttgctg                                            26


<210>  4
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Tie2cre Rv primer

<400>  4
ggacatgttc agggatcgcc aggcg                                             25


